Pharma Co. Humanigen Gets OK For Ch. 11 Sale

By Clara Geoghegan · February 14, 2024, 7:40 PM EST

Drug researcher Humanigen Inc. can sell nearly all of its assets to a company formed by its CEO, a Delaware bankruptcy judge ruled Wednesday, after the debtor, the buyer and the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Humanigen, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

January 03, 2024

Recent Articles By Clara

May 17, 2024
Steward Health Ch. 11 Lifts Lid On PE In Healthcare
April 19, 2024
Life Sciences Biz NanoString Gets OK For $393M Ch. 11 Sale
March 25, 2024
Judge Probes If $54M Deal Will Affect Tehum Care Ch. 11 Plan
March 05, 2024
Rite Aid Process To Break Leases, Close Stores In Ch. 11 OK'd
February 13, 2024
FDA, Creditors Oppose Drugmaker Humanigen's Ch. 11 Sale
January 29, 2024
Shumaker Can't Get Double Fees For Appeal, Wilkes Says
January 25, 2024
Service Snag Delays Hospital Operator's Ch. 11 Confirmation
January 22, 2024
Medical Software Co. Eye Care Leaders OK'd For Joint Ch. 11
January 19, 2024
UpHealth's 'Full Pay' Ch. 11 Plan On Horizon, Committee Says
December 20, 2023
Biochemical Co. Amyris OK'd To Sell Celebrity Brands